ライフサイエンスコーパス: bacterial keratitis

1 models, the present study tested its role in bacterial keratitis.

2 ical corticosteroid treatment on outcomes in bacterial keratitis.

3 mediated corneal damage resulting from acute bacterial keratitis.

4 or an epithelial plaque was associated with bacterial keratitis.

5 expression and activation after induction of bacterial keratitis.

6 present with an increased susceptibility to bacterial keratitis.

7 ble in the developing world for treatment of bacterial keratitis.

8 ple method for the investigation of presumed bacterial keratitis.

9 evaluated for virulence in a mouse model of bacterial keratitis.

10 ungal keratitis, and contact lens-associated bacterial keratitis.

11 otic may be appropriate for certain cases of bacterial keratitis.

12 e for identifying pathogens in patients with bacterial keratitis.

13 ulture infections model and in vivo model of bacterial keratitis.

14 ids to topical moxifloxacin hydrochloride in bacterial keratitis.

15 Of 95 patients with bacterial keratitis, 103 patients with fungal keratitis,

16 Of a total of 224 patients with bacterial keratitis, 114 patients were randomized to gro

17 cords of 115 patients with laboratory-proven bacterial keratitis, 115 patients with laboratory-proven

18 Thirty-eight out of 44 cases of bacterial keratitis (86.36%) were diagnosed by solid med

19 In bacterial keratitis, a higher MIC to the treating antibi

20 e of therapeutic value for the management of bacterial keratitis, a prevalent cause of vision loss an

21 n was recovered in 977 samples (57.4%), with bacterial keratitis accounting for 897 of the positive c

22 ium phosphate to placebo in the treatment of bacterial keratitis among 500 patients with culture-posi

23 ections and is commonly isolated in cases of bacterial keratitis, an infection of the cornea.

24 TOR regulates IL-10 in P. aeruginosa-induced bacterial keratitis and is critical to balancing pro- an

25 al antibiotics remain the best treatment for bacterial keratitis, and a recent review found all commo

26 causative organisms and clinical outcome in bacterial keratitis, and is likely on the causal pathway

27 confidence in making the proper diagnosis of bacterial keratitis, and the level of trust in the antib

28 method) is as reliable for the diagnosis of bacterial keratitis as inoculation of multiple scrapes d

29 entous fungal keratitis and 24 patients with bacterial keratitis (as controls).

30 Microbiology records of suspected bacterial keratitis cases that underwent a diagnostic co

31 uginosa is a common organism associated with bacterial keratitis, especially in extended-wear contact

32 on with topical antibiotics for treatment of bacterial keratitis in areas of the world where use of e

33 This is the first report of spontaneous bacterial keratitis in mice.

34 ponse propensity affects the pathogenesis of bacterial keratitis in mice.

35 e shows delayed healing and poor clearing of bacterial keratitis; in vitro its epithelial protein ext

36 CD36(-/-) mice develop spontaneous bacterial keratitis independent of TLR2 and TSP1.

37 Bacterial keratitis is a sight-threatening infection of

38 ancomycin in the setting of severe suspected bacterial keratitis may be justified.

39 rabbit model of soft contact lens-associated bacterial keratitis more often than its collagen-binding

40 Ocular bacterial keratitis, often associated with Pseudomonas a

41 ghty photographs of eyes with culture-proven bacterial keratitis or smear-proven fungal keratitis wer

42 Nine (82%) of 11 bacterial keratitis patients were PCR positive; each seq

43 Scarring from bacterial keratitis remains a leading cause of visual lo

44 identification of pathogens in patients with bacterial keratitis remains problematic because standard

45 We randomized 172 individuals with bacterial keratitis to topical treatment with povidone-i

46 tion of the causative organisms in suspected bacterial keratitis traditionally involves collecting mu

47 All cases of bacterial keratitis treated at the University of Illinoi

48 causative organisms and clinical outcome in bacterial keratitis using data collected in a randomized

49 al infections of the eye can lead to corneal bacterial keratitis, visual impairment, and blindness.

50 The rate of culture-positive bacterial keratitis was 0.022 infections per eye-year, a

51 a well-characterized in vivo rabbit model of bacterial keratitis was selected to study its contributi

52 Patients with suspected bacterial keratitis were identified from microbiological

53 rneal densitometry readings in subjects with bacterial keratitis were recorded during the active stag

54 Recurrence and secondary bacterial keratitis were seen in 28 (14.5%) and 20 (10%)

55 thy controls and 36 eyes of 35 patients with bacterial keratitis were studied.

56 xpensive, can be considered for treatment of bacterial keratitis when antibiotic treatment is not pra

57 irst study to explore the role of miR-155 in bacterial keratitis, which may provide a promising targe

58 en patients had microbiologically documented bacterial keratitis, while 17 patients had keratitis due

59 of a simpler diagnostic method in suspected bacterial keratitis would be useful.